There is unfortunate breaking news that the FDA Panel has approved the return of Vioxx to the market by a vote of 17-15, strongly favored keeping Celebrex on the market, and split over Bextra remaining on market. While the panel's recommendations are

This is an utter trajedy! This decision comes only hours after briggs morrison was confronted with merck docs showing vioxx increased the risk of death (not heart attack or stroke) by 4.5 fold.many people are going to be injured by this decision.